First-in-human gene therapy launches for pediatric patient with rare neurogenerative disease 

In May, a ten-year-old girl named JoJo received gene therapy for an extremely rare neurogenerative disease called GM1 gangliosidosis. GM1 progressively destroys nerve cells (neurons) in the brain and spinal cord, leading to muscle and movement weakness, difficulty swallowing and a shortened life expectancy.